Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 234.00
Bid: 233.50
Ask: 234.50
Change: 2.00 (0.86%)
Spread: 1.00 (0.428%)
Open: 231.50
High: 234.50
Low: 231.50
Prev. Close: 232.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Spire Cheshire Hospital sale and leaseback

22 Dec 2021 07:00

RNS Number : 4136W
Spire Healthcare Group PLC
22 December 2021
 

Spire Healthcare Group plc

 

("Spire Healthcare", "the Company" or "the Group")

 

Spire Cheshire Hospital sale and leaseback

 

22 December 2021

 

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, announces it has agreed terms to sell the freehold assets of Spire Cheshire through the sale of the shares in a wholly owned subsidiary in which the property is held to NWI Jersey Ltd. for £89m in cash before costs, generating a book profit of approximately £23m on gross assets of £66m. Spire Healthcare will continue to operate the hospital and will lease the property at an initial rent of £3.8m, with annual rent inflation linked to CPI and capped at 4%.

 

Net proceeds after deal costs and applicable taxes are expected to be £85m. In FY22, Spire Healthcare's lease liabilities under IFRS 16 will increase by £56m to c.£800m, and net finance costs will rise by £3m with negligible impact to depreciation.

 

Spire Cheshire is a medium-sized hospital rated Outstanding by the CQC, comprising 46 beds, 3 main theatres and a minor operations room. The hospital generates an EBITDA margin in line with the Group average and the transaction will have no impact on the operation of the hospital or patient care.

 

The sale proceeds of the transaction will be used to provide financial flexibility for post COVID opportunities, and an improved cash position while COVID-19 uncertainty continues and the Company undertakes to re-finance its existing bank debt in 2022, which is due to mature in mid-2023. The freehold sale also presents an excellent opportunity to demonstrate the value of the Group's freehold property portfolio.

 

Following the transaction, the acquisition of the Claremont hospital, which completed on 30 November 2021, and the sale of the Sussex hospital, which is due to complete in Q1 2022, Spire Healthcare will comprise 19 freehold and 20 leased properties. Spire Healthcare has always maintained a proactive approach to portfolio management. The Company fully considers the risks and benefits of freehold versus leasehold properties and seeks to maintain a prudent balance between the two.

 

Supplementary information update

The supplementary information provided at the interim results on 9 September has been updated. In Q1, the Company operated under an NHS contract. The updated supplementary information provides a breakdown of costs in Q2 to go alongside revenue breakdowns already provided. This breakdown shows a gross margin of 42.2% in Q2. The supplementary information in respect of Q2 can be found on the Spire Healthcare website at https://investors.spirehealthcare.com/investors/reports-and-accounts/

 

Spire Healthcare will report its FY21 results on 3 March 2022.

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

Angus Prentice

 

 

+44 (0)7974 982 512

 

Instinctif Partners

Damian Reece

Guy Scarborough

Jeremy Durrant

 

+44 (0)7931 598 593

+44 (0)7917 178 920

+44 (0)7792 918 648

Registered Office and Head Office:

 

Spire Healthcare Group plc3 Dorset RiseLondonEC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics across England, Wales and Scotland.

 

Working in partnership with around 7,500 experienced consultants, Spire Healthcare delivered tailored, personalised care to almost 750,000 in-patients and daycase patients in 2020, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

 

The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 90% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).

 

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKDBDCBDDKBB
Date   Source Headline
28th Mar 20241:54 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNotice of Capital Markets Event
15th Mar 202410:07 amRNSDirector/PDMR Shareholding
1st Mar 20244:35 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSCFO transition
29th Feb 20247:00 amRNSFinal Results
13th Feb 20247:31 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights and Capital
29th Jan 20247:00 amRNSNotice of Preliminary Results
11th Jan 20243:18 pmRNSBlock listing Interim Review
1st Dec 20237:00 amRNSTotal Voting Rights and Capital
1st Nov 20239:47 amRNSTotal Voting Rights
20th Oct 202311:21 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSAcquisition of Vita Health Group
2nd Oct 20232:57 pmRNSTotal Voting Rights
2nd Oct 20239:19 amRNSBlock listing Interim Review
14th Sep 20237:00 amRNSHalf-year Report
1st Sep 20233:52 pmRNSTotal Voting Rights
11th Aug 20238:15 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSNotice of Interim Results
1st Aug 20239:04 amRNSTotal Voting Rights
13th Jul 20233:15 pmRNSDirector Declaration
11th Jul 20237:49 amRNSBlock listing Interim Review
1st Jun 20239:12 amRNSTotal Voting Rights
11th May 20232:20 pmRNSResults of 2023 Annual General Meeting
11th May 20237:00 amRNSAGM Statement
12th Apr 20234:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:04 pmRNSAnnual Financial Report
3rd Apr 20238:07 amRNSTotal Voting Rights
30th Mar 20233:18 pmRNSBlock listing Interim Review
30th Mar 20232:48 pmRNSDirector/PDMR Shareholding
16th Mar 202310:00 amRNSDirector/PDMR Shareholding
9th Mar 20239:18 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
28th Feb 20234:01 pmRNSDirector Declaration
9th Feb 20237:00 amRNSPreliminary Results Presentation – Change of Venue
1st Feb 202310:52 amRNSTotal Voting Rights
23rd Jan 20237:00 amRNSNotice of Preliminary Results
20th Jan 20239:30 amRNSDirector Declaration
12th Jan 20239:42 amRNSBlock listing Interim Review
3rd Jan 20232:00 pmRNSTotal Voting Rights
19th Dec 20227:00 amRNSAcquisition of The Doctors Clinic Group Limited
1st Dec 202210:02 amRNSTotal Voting Rights
1st Nov 20221:24 pmRNSTotal Voting Rights
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.